Maria‐Veronica Teleanu

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka et al. · Blood · 2013 · 178 citations

Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with <i>NPM1</i>-mutated AML: results from the AMLSG 09-09 trial

Silke Kapp‐Schwoerer, Daniela Weber, Andrea Corbacioglu et al. · Blood · 2020 · 115 citations · Full text

Midostaurin in Combination with Intensive Induction and As Single Agent Maintenance Therapy after Consolidation Therapy with Allogeneic Hematopoietic Stem Cell Transplantation or High-Dose Cytarabine (NCT01477606)

Richard F. Schlenk, Konstanze Döhner, Helmut R. Salih et al. · Blood · 2015 · 43 citations

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

Andreas Möck, Maria‐Veronica Teleanu, Simon Kreutzfeldt et al. · npj Precision Oncology · 2023 · 29 citations · Full text

Outcome of immunotherapy in adrenocortical carcinoma: a retrospective cohort study

Hanna Remde, Laura Schmidt-Pennington, Miriam Reuter et al. · European Journal of Endocrinology · 2023 · 25 citations